Alzheimer's disease (AD) is a common neurodegenerative disease characterized by amyloid-β (Aβ) deposition and neurofibrillary tangles formed by high phosphorylation of tau protein. At present, drug therapy is the main strategy of AD treatment, but its effects are limited to delaying or alleviating AD. Recently, non-pharmacologic intervention has attracted more attention, and more studies have confirmed that non-pharmacologic intervention in AD can improve the patient's cognitive function and quality of life. This paper summarizes the current non-pharmacologic intervention in AD, to provide useful supplementary means for AD intervention.
TerryRDPeckADeTeresaR, et al.Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol1981; 10: 184–192.
2.
SunB-LLiW-WZhuC, et al.Clinical research on Alzheimer's disease: progress and perspectives. Neurosci Bull2018; 34: 1111–1118.
3.
ScheltensPDe StrooperBKivipeltoM, et al.Alzheimer's disease. Lancet2021; 397: 1577–1590.
4.
YiannopoulouKGPapageorgiouSG. Current and future treatments in Alzheimer disease: an update. J Cent Nerv Syst Dis2020; 12: 1179573520907397.
5.
2022 Alzheimer's disease facts and figures. Alzheimers Dement2022; 18: 700–789.
6.
LiW-YGaoJ-YLinS-Y, et al.Effects of involuntary and voluntary exercise in combination with acousto-optic stimulation on adult neurogenesis in an Alzheimer's mouse model. Mol Neurobiol2022; 59: 3254–3279.
7.
LiuZ-TMaY-TPanS-T, et al.Effects of involuntary treadmill running in combination with swimming on adult neurogenesis in an Alzheimer's mouse model. Neurochem Int2022; 155: 105309.
8.
MathysHPengZBoixCA, et al.Single-cell atlas reveals correlates of high cognitive function, dementia, and resilience to Alzheimer's disease pathology. Cell2023; 186: 4365–4385.e27.
9.
HampelH. Amyloid-β and cognition in aging and Alzheimer's disease: molecular and neurophysiological mechanisms. J Alzheimers Dis2013; 33: S79–S86.
10.
Bahar-FuchsAWebbSBartschL, et al.Tailored and adaptive computerized cognitive training in older adults at risk for dementia: a randomized controlled trial. J Alzheimers Dis2017; 60: 889–911.
11.
TárragaLBoadaMModinosG, et al.A randomised pilot study to assess the efficacy of an interactive, multimedia tool of cognitive stimulation in Alzheimer's disease. J Neurol Neurosurg Psychiatry2006; 77: 1116–1121.
12.
TrebbastoniAImbrianoLPoddaL, et al.Cognitive training in patients with Alzheimer's disease: findings of a 12-month randomized controlled trial. Curr Alzheimer Res2018; 15: 452–461.
13.
ClareLWoodsRTMoniz CookED, et al.Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia. Cochrane Database Syst Rev2003; 4: CD003260.
14.
Van BogaertPVan GrinsvenRTolsonD, et al.Effects of SolCos model-based individual reminiscence on older adults with mild to moderate dementia due to Alzheimer disease: a pilot study. J Am Med Dir Assoc2013; 14: 528.e529–5528.513.
15.
ChanJYCChanTKKwokTCY, et al.Cognitive training interventions and depression in mild cognitive impairment and dementia: a systematic review and meta-analysis of randomized controlled trials. Age Ageing2020; 49: 738–747.
16.
BrueggenKKasperEOchmannS, et al.Cognitive rehabilitation in Alzheimer's disease: a controlled intervention trial. J Alzheimers Dis2017; 57: 1315–1324.
17.
AmievaHRobertPHGrandoulierA-S, et al.Group and individual cognitive therapies in Alzheimer's disease: the ETNA3 randomized trial. Int Psychogeriatr2016; 28: 707–717.
18.
ShelineYIMorrisJCSnyderAZ, et al.APOE4 Allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Aβ42. J Neurosci2010; 30: 17035–17040.
19.
ChandraADervenoulasGPolitisM. Magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment. J Neurol2019; 266: 1293–1302.
20.
MaassADüzelSGoerkeM, et al.Vascular hippocampal plasticity after aerobic exercise in older adults. Mol Psychiatry2015; 20: 585–593.
21.
GbiriCAOAmusaBF. Progressive task-oriented circuit training for cognition, physical functioning and societal participation in individuals with dementia. Physiother Res Int2020; 25: e1866.
22.
HendrikseJChyeYThompsonS, et al.Regular aerobic exercise is positively associated with hippocampal structure and function in young and middle-aged adults. Hippocampus2022; 32: 137–152.
23.
JainALamarkTSjøttemE, et al.P62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem2010; 285: 22576–22591.
24.
Ohia-NwokoOMontazariSLauY-S, et al.Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice. Mol Neurodegener2014; 9: 54.
25.
WinkelmanC. Inactivity and inflammation: selected cytokines as biologic mediators in muscle dysfunction during critical illness. AACN Clin Issues2004; 15: 74–82.
26.
SpielmanLJLittleJPKlegerisA. Physical activity and exercise attenuate neuroinflammation in neurological diseases. Brain Res Bull2016; 125: 19–29.
27.
PedersenBKFebbraioM. Muscle-derived interleukin-6–a possible link between skeletal muscle, adipose tissue, liver, and brain. Brain Behav Immun2005; 19: 371–376.
28.
KellyÁM. Exercise-induced modulation of neuroinflammation in models of Alzheimer's disease. Brain Plast2018; 4: 81–94.
29.
HanHZhaoYDuJ, et al.Exercise improves cognitive dysfunction and neuroinflammation in mice through Histone H3 lactylation in microglia. Immun Ageing2023; 20: 63.
30.
FrancisNRobisonLSPopescuDL, et al.Voluntary wheel running reduces amyloid-β42 and rescues behavior in aged Tg2576 mouse model of Alzheimer's disease. J Alzheimers Dis2020; 73: 359–374.
31.
ZengBZhaoGLiuHL. The differential effect of treadmill exercise intensity on hippocampal soluble Aβ and lipid metabolism in APP/PS1 mice. Neuroscience2020; 430: 73–81.
32.
LeeD-YImS-CKangN-Y, et al.Analysis of effect of intensity of aerobic exercise on cognitive and motor functions and neurotrophic factor expression patterns in an Alzheimer's disease rat model. J Pers Med2023; 13: 1622.
33.
RashidMHZahidMFZainS, et al.The neuroprotective effects of exercise on cognitive decline: a preventive approach to Alzheimer disease. Cureus2020; 12: e6958.
34.
LiangY-JSuQ-WShengZ-R, et al.Effectiveness of physical activity interventions on cognition, neuropsychiatric symptoms, and quality of life of Alzheimer's disease: an update of a systematic review and meta-analysis. Front Aging Neurosci2022; 14: 830824.
35.
AczelDGyorgyBBakonyiP, et al.The systemic effects of exercise on the systemic effects of Alzheimer's disease. Antioxidants (Basel)2022; 11: 1028.
36.
SunL-NLiX-LWangF, et al.High-intensity treadmill running impairs cognitive behavior and hippocampal synaptic plasticity of rats via activation of inflammatory response. J Neurosci Res2017; 95: 1611–1620.
37.
LambSESheehanBAthertonN, et al.Dementia and physical activity (DAPA) trial of moderate to high intensity exercise training for people with dementia: randomised controlled trial. BMJ2018; 361: k1675.
38.
AliNTianHThabaneL, et al.The effects of dual-task training on cognitive and physical functions in older adults with cognitive impairment; A systematic review and meta-analysis. J Prev Alzheimers Dis2022; 9: 359–370.
39.
KochGBonnìSPellicciariMC, et al.Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer's disease. Neuroimage2018; 169: 302–311.
40.
Drumond MarraHLMyczkowskiMLMaia MemóriaC, et al.Transcranial magnetic stimulation to address mild cognitive impairment in the elderly: a randomized controlled study. Behav Neurol2015; 2015: 287843.
41.
FabelKKempermannG. Physical activity and the regulation of neurogenesis in the adult and aging brain. Neuromolecular Med2008; 10: 59–66.
42.
TerranovaCSantAngeloAMorganteF, et al.Impairment of sensory-motor plasticity in mild Alzheimer's disease. Brain Stimul2013; 6: 62–66.
43.
KempermannGFabelKEhningerD, et al.Why and how physical activity promotes experience-induced brain plasticity. Front Neurosci2010; 4: 189.
44.
BattagliaFWangH-YGhilardiMF, et al.Cortical plasticity in Alzheimer's disease in humans and rodents. Biol Psychiatry2007; 62: 1405–1412.
45.
LamLC-WChanWCLeungT, et al.Would older adults with mild cognitive impairment adhere to and benefit from a structured lifestyle activity intervention to enhance cognition?: a cluster randomized controlled trial. PloS One2015; 10: e0118173.
46.
Singh MAFGatesNSaigalN, et al.The study of mental and resistance training (SMART) study—resistance training and/or cognitive training in mild cognitive impairment: a randomized, double-blind, double-sham controlled trial. J Am Med Dir Assoc2014; 15: 873–880.
47.
BhererL. Cognitive plasticity in older adults: effects of cognitive training and physical exercise. Ann N Y Acad Sci2015; 1337: 1–6.
48.
ChangC-HLaneH-YLinC-H. Brain stimulation in Alzheimer's disease. Front Psychiatry2018; 9: 201.
49.
HansenN. Brain stimulation for combating Alzheimer's disease. Front Neurol2014; 5: 80.
50.
PonceFAAsaadWFFooteKD, et al.Bilateral deep brain stimulation of the fornix for Alzheimer's disease: surgical safety in the Advance trial. J Neurosurg2016; 125: 75–84.
51.
XiaFYiuAStoneSSD, et al.Entorhinal cortical deep brain stimulation rescues memory deficits in both young and old mice genetically engineered to model Alzheimer's disease. Neuropsychopharmacology2017; 42: 2493–2503.
52.
ZhuHYanHTangN, et al.Impairments of spatial memory in an Alzheimer's disease model via degeneration of hippocampal cholinergic synapses. Nat Commun2017; 8: 1676.
53.
ScharreDWWeichartENielsonD, et al.Deep brain stimulation of frontal lobe networks to treat Alzheimer's disease. J Alzheimers Dis2018; 62: 621–633.
54.
HaoSTangBWuZ, et al.Forniceal deep brain stimulation rescues hippocampal memory in Rett syndrome mice. Nature2015; 526: 430–434.
55.
JafariZKolbBEMohajeraniMH. Neural oscillations and brain stimulation in Alzheimer's disease. Prog Neurobiol2020; 194: 101878.
56.
LozanoAMFosdickLChakravartyMM, et al.A phase II study of fornix deep brain stimulation in mild Alzheimer's disease. J Alzheimers Dis2016; 54: 777–787.
57.
MannAGondardETampelliniD, et al.Chronic deep brain stimulation in an Alzheimer's disease mouse model enhances memory and reduces pathological hallmarks. Brain Stimul2018; 11: 435–444.
58.
YangXYaoCTianT, et al.A novel mechanism of memory loss in Alzheimer's disease mice via the degeneration of entorhinal-CA1 synapses. Mol Psychiatry2018; 23: 199–210.
59.
TrösterAIMeadorKJIrwinCP, et al.Memory and mood outcomes after anterior thalamic stimulation for refractory partial epilepsy. Seizure2017; 45: 133–141.
60.
LuberBMcClintockSMLisanbySH. Applications of transcranial magnetic stimulation and magnetic seizure therapy in the study and treatment of disorders related to cerebral aging. Dialogues Clin Neurosci2013; 15: 87–98.
61.
D'AmicoJMDongésSCTaylorJL. High-intensity, low-frequency repetitive transcranial magnetic stimulation enhances excitability of the human corticospinal pathway. J Neurophysiol2020; 123: 1969–1978.
62.
HuangZTanTDuY, et al.Low-frequency repetitive transcranial magnetic stimulation ameliorates cognitive function and synaptic plasticity in APP23/PS45 mouse model of Alzheimer's disease. Front Aging Neurosci2017; 9: 292.
63.
MaJZhangZKangL, et al.Repetitive transcranial magnetic stimulation (rTMS) influences spatial cognition and modulates hippocampal structural synaptic plasticity in aging mice. Exp Gerontol2014; 58: 256–268.
64.
CaoHZuoCGuZ, et al.High frequency repetitive transcranial magnetic stimulation alleviates cognitive deficits in 3xTg-AD mice by modulating the PI3K/Akt/GLT-1 axis. Redox Biol2022; 54: 102354.
65.
LiaoXLiGWangA, et al.Repetitive transcranial magnetic stimulation as an alternative therapy for cognitive impairment in Alzheimer's disease: a meta-analysis. J Alzheimers Dis2015; 48: 463–472.
66.
LinYJiangW-JShanP-Y, et al.The role of repetitive transcranial magnetic stimulation (rTMS) in the treatment of cognitive impairment in patients with Alzheimer's disease: a systematic review and meta-analysis. J Neurol Sci2019; 398: 184–191.
67.
KochGCasulaEPBonnìS, et al.Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial. Brain2022; 145: 3776–3786.
68.
AhmedMADarwishESKhedrEM, et al.Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer's dementia. J Neurol2012; 259: 83–92.
69.
WuXYanYHuP, et al.Effects of a periodic intermittent theta burst stimulation in Alzheimer's disease. Gen Psychiatr2024; 37: e101106.
70.
StanojevicJBZeljkovicMDragicM, et al.Intermittent theta burst stimulation attenuates oxidative stress and reactive astrogliosis in the streptozotocin-induced model of Alzheimer's disease-like pathology. Front Aging Neurosci2023; 15: 1161678.
71.
ZhuYHuangHChenZ, et al.Intermittent theta burst stimulation attenuates cognitive deficits and Alzheimer's disease-type pathologies via ISCA1-mediated mitochondrial modulation in APP/PS1 mice. Neurosci Bull2024; 40: 182–200.
72.
JungYHJangHParkS, et al.Effectiveness of personalized hippocampal network-targeted stimulation in Alzheimer disease: a randomized clinical trial. JAMA Netw Open2024; 7: e249220.
73.
KhedrEMGamalNFEEl-FetohNA, et al.A double-blind randomized clinical trial on the efficacy of cortical direct current stimulation for the treatment of Alzheimer's disease. Front Aging Neurosci2014; 6: 275.
74.
FerrucciRMameliFGuidiI, et al.Transcranial direct current stimulation improves recognition memory in Alzheimer disease. Neurology2008; 71: 493–498.
75.
AntalAPaulusW. Transcranial alternating current stimulation (tACS). Front Hum Neurosci2013; 7: 317.
76.
NitscheMAPaulusW. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol2000; 527: 633–639.
77.
KuoM-FNitscheMA. Effects of transcranial electrical stimulation on cognition. Clin EEG Neurosci2012; 43: 192–199.
78.
ZarifkarAHZarifkarANamiM, et al.Ameliorative effects of different transcranial electrical stimulation paradigms on the novel object recognition task in a rat model of Alzheimer disease. Galen Med J2019; 8: e1440.
79.
DhaynautMSprugnoliGCapponD, et al.Impact of 40 hz transcranial alternating current stimulation on cerebral tau burden in patients with Alzheimer's disease: a case series. J Alzheimers Dis2022; 85: 1667–1676.
80.
BenussiACantoniVCotelliMS, et al.Exposure to gamma tACS in Alzheimer's disease: a randomized, double-blind, sham-controlled, crossover, pilot study. Brain Stimul2021; 14: 531–540.
81.
TruongDQThomasCHampsteadBM, et al.Comparison of transcranial focused ultrasound and transcranial pulse stimulation for neuromodulation: a computational study. Neuromodulation2022; 25: 606–613.
82.
LegonWSatoTFOpitzA, et al.Transcranial focused ultrasound modulates the activity of primary somatosensory cortex in humans. Nat Neurosci2014; 17: 322–329.
83.
LegonWAiLBansalP, et al.Neuromodulation with single-element transcranial focused ultrasound in human thalamus. Hum Brain Mapp2018; 39: 1995–2006.
84.
CollinsMNLegonWMesceKA. The inhibitory thermal effects of focused ultrasound on an identified, single motoneuron. eNeuro2021; 8: ENEURO.0514-20.2021.
85.
MuellerJKAiLBansalP, et al.Numerical evaluation of the skull for human neuromodulation with transcranial focused ultrasound. J Neural Eng2017; 14: 066012.
86.
MattEDörlGBeisteinerR. Transcranial pulse stimulation (TPS) improves depression in AD patients on state-of-the-art treatment. Alzheimers Dement (N Y)2022; 8: e12245.
87.
ChenXYouJMaH, et al.Transcranial pulse stimulation in Alzheimer's disease. CNS Neurosci Ther2024; 30: e14372.
88.
AdairDTruongDEsmaeilpourZ, et al.Electrical stimulation of cranial nerves in cognition and disease. Brain Stimul2020; 13: 717–750.
89.
SjögrenMJCHellströmPTOJonssonMAG, et al.Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot study. J Clin Psychiatry2002; 63: 972–980.
90.
MerrillCAJonssonMAGMinthonL, et al.Vagus nerve stimulation in patients with Alzheimer's disease: additional follow-up results of a pilot study through 1 year. J Clin Psychiatry2006; 67: 1171–1178.
91.
SilbersteinSDYuanHNajibU, et al.Non-invasive vagus nerve stimulation for primary headache: a clinical update. Cephalalgia2020; 40: 1370–1384.
92.
JacobsHILRiphagenJMRazatCM, et al.Transcutaneous vagus nerve stimulation boosts associative memory in older individuals. Neurobiol Aging2015; 36: 1860–1867.
93.
FarmerADStrzelczykAFinisguerraA, et al.International consensus based review and recommendations for Minimum reporting standards in research on transcutaneous Vagus nerve stimulation (Version 2020). Front Hum Neurosci2020; 14: 568051.
94.
SatohMYubaTTabeiK-I, et al.Music therapy using singing training improves psychomotor speed in patients with Alzheimer's disease: a neuropsychological and fMRI study. Dement Geriatr Cogn Dis Extra2015; 5: 296–308.
95.
Meilán GarcíaJJIodiceRCarroJ, et al.Improvement of autobiographic memory recovery by means of sad music in Alzheimer's disease type dementia. Aging Clin Exp Res2012; 24: 227–232.
96.
Arroyo-AnllóEMDíazJPGilR. Familiar music as an enhancer of self-consciousness in patients with Alzheimer's disease. Biomed Res Int2013; 2013: 752965.
97.
GlachetOGandolpheM-CGalloujK, et al.Effects of olfactory stimulation on autobiographical memory in Alzheimer's disease. Geriatr Psychol Neuropsychiatr Vieil2018; 16: 311–320.
98.
GlachetOEl HajM. Effects of olfactory stimulation on past and future thinking in Alzheimer's disease. Chem Senses2020; 45: 313–320.
99.
Van HoofJAartsMPRenseC, et al.Ambient bright light in dementia: effects on behaviour and circadian rhythmicity. Build Environ2009; 44: 146–155.
100.
GriffithsBJParishGRouxF, et al.Directional coupling of slow and fast hippocampal gamma with neocortical alpha/beta oscillations in human episodic memory. Proc Natl Acad Sci U S A2019; 116: 21834–21842.
101.
CimenserAHempelETraversT, et al.Sensory-evoked 40-Hz gamma oscillation improves sleep and daily living activities in Alzheimer's disease patients. Front Syst Neurosci2021; 15: 746859.
102.
IaccarinoHFSingerACMartorellAJ, et al.Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature2016; 540: 230–235.
103.
SingerACMartorellAJDouglasJM, et al.Noninvasive 40-Hz light flicker to recruit microglia and reduce amyloid beta load. Nat Protoc2018; 13: 1850–1868.
104.
AdaikkanCMiddletonSJMarcoA, et al.Gamma entrainment binds higher-order brain regions and offers neuroprotection. Neuron2019; 102: 929–943.e8.
105.
NazariMVajed-SamieiTTorabiN, et al.The 40-Hz white light-emitting diode (LED) improves the structure-function of the brain mitochondrial KATP channel and respiratory chain activities in amyloid beta toxicity. Mol Neurobiol2022; 59: 2424–2440.
106.
Tanaka-KoshiyamaKKoshiyamaDMiyakoshiM, et al.Abnormal spontaneous gamma power is associated with verbal learning and memory dysfunction in schizophrenia. Front Psychiatry2020; 11: 832.
107.
MartorellAJPaulsonALSukH-J, et al.Multi-sensory gamma stimulation ameliorates Alzheimer's-associated pathology and improves cognition. Cell2019; 177: 256–271.e22.
108.
ChanDSukHJJacksonB, et al.Induction of specific brain oscillations may restore neural circuits and be used for the treatment of Alzheimer's disease. J Intern Med2021; 290: 993–1009.
109.
WuLCaoTLiS, et al.Long-term gamma transcranial alternating current stimulation improves the memory function of mice with Alzheimer's disease. Front Aging Neurosci2022; 14: 980636.
110.
ParkMHoangGMNguyenT, et al.Effects of transcranial ultrasound stimulation pulsed at 40 Hz on Aβ plaques and brain rhythms in 5×FAD mice. Transl Neurodegener2021; 10: 48.
111.
IsmailRHansenAKParboP, et al.The effect of 40-Hz light therapy on amyloid load in patients with prodromal and clinical Alzheimer's disease. Int J Alzheimers Dis2018; 2018: 6852303.
112.
Clements-CortesAAhonenHEvansM, et al.Short-term effects of rhythmic sensory stimulation in Alzheimer's disease: an exploratory pilot study. J Alzheimers Dis2016; 52: 651–660.
113.
MegerianJHajosMHempelE, et al.Feasibility, safety, and efficacy of gamma sensory stimulation as a novel therapeutic intervention for Alzheimer’s disease (N1. 001). Neurology2022; 98: 1936.
114.
HeQColon-MotasKMPybusAF, et al.A feasibility trial of gamma sensory flicker for patients with prodromal Alzheimer's disease. Alzheimers Dement (N Y)2021; 7: e12178.
115.
DrapeauJGosselinNGagnonL, et al.Emotional recognition from face, voice, and music in dementia of the Alzheimer type. Ann N Y Acad Sci2009; 1169: 342–345.
116.
KingJBJonesKGGoldbergE, et al.Increased functional connectivity after listening to favored music in adults with Alzheimerd ementia. J Prev Alzheimers Dis2019; 6: 56–62.
117.
ReinhartRMGNguyenJA. Working memory revived in older adults by synchronizing rhythmic brain circuits. Nat Neurosci2019; 22: 820–827.
118.
SalimpoorVNBenovoyMLarcherK, et al.Anatomically distinct dopamine release during anticipation and experience of peak emotion to music. Nat Neurosci2011; 14: 257–262.
119.
GarcíaELBanegasJRPérez-RegaderaAG, et al.Social network and health-related quality of life in older adults: a population-based study in Spain. Qual Life Res2005; 14: 511–520.
120.
LyuJZhangJMuH, et al.The effects of music therapy on cognition, psychiatric symptoms, and activities of daily living in patients with Alzheimer's disease. J Alzheimers Dis2018; 64: 1347–1358.
121.
ChenBZhongXMaiN, et al.Cognitive impairment and structural abnormalities in late life depression with olfactory identification impairment: an Alzheimer's disease-like pattern. Int J Neuropsychopharmacol2018; 21: 640–648.
122.
PostuPASadikiFZEl IdrissiM, et al.Pinus halepensis essential oil attenuates the toxic Alzheimer's amyloid beta (1–42)-induced memory impairment and oxidative stress in the rat hippocampus. Biomed Pharmacother2019; 112: 108673.
123.
MurrayHCDieriksBVSwansonMEV, et al.The unfolded protein response is activated in the olfactory system in Alzheimer's disease. Acta Neuropathol Commun2020; 8: 109.
124.
ArshamianAIannilliEGerberJC, et al.The functional neuroanatomy of odor evoked autobiographical memories cued by odors and words. Neuropsychologia2013; 51: 123–131.
125.
LarssonMWillanderJKarlssonK, et al.Olfactory LOVER: behavioral and neural correlates of autobiographical odor memory. Front Psychol2014; 5: 312.
126.
RuffJHassanNMorales-ZavalaF, et al.CLPFFD-PEG functionalized NIR-absorbing hollow gold nanospheres and gold nanorods inhibit β-amyloid aggregation. J Mater Chem B2018; 6: 2432–2443.
127.
GratuzeMHoltzmanDM. Targeting pre-synaptic tau accumulation: a new strategy to counteract tau-mediated synaptic loss and memory deficits. Neuron2021; 109: 741–743.
128.
LiMGuanYZhaoA, et al.Using multifunctional peptide conjugated Au nanorods for monitoring β-amyloid aggregation and chemo-photothermal treatment of Alzheimer's disease. Theranostics2017; 7: 2996–3006.
129.
XiongRRaemdonckKPeynshaertK, et al.Comparison of gold nanoparticle mediated photoporation: vapor nanobubbles outperform direct heating for delivering macromolecules in live cells. ACS Nano2014; 8: 6288–6296.
130.
LinDHeRLiS, et al.Highly efficient destruction of amyloid-β fibrils by femtosecond laser-induced nanoexplosion of gold nanorods. ACS Chem Neurosci2016; 7: 1728–1736.
131.
SudhakarSSanthoshPBManiE. Dual role of gold nanorods: inhibition and dissolution of aβ fibrils induced by near IR laser. ACS Chem Neurosci2017; 8: 2325–2334.
132.
YinTXieWSunJ, et al.Penetratin peptide-functionalized gold nanostars: enhanced BBB permeability and NIR photothermal treatment of Alzheimer's disease using ultralow irradiance. ACS Appl Mater Interfaces2016; 8: 19291–19302.
133.
SudhakarSManiE. Rapid dissolution of amyloid β fibrils by silver nanoplates. Langmuir2019; 35: 6962–6970.
134.
GongLZhangXGeK, et al.Carbon nitride-based nanocaptor: an intelligent nanosystem with metal ions chelating effect for enhanced magnetic targeting phototherapy of Alzheimer's disease. Biomaterials2021; 267: 120483.
135.
RuiL. Brown and beige adipose tissues in health and disease. Compr Physiol2017; 7: 1281–1306.
136.
TournissacMVandalMFrançoisA, et al.Old age potentiates cold-induced tau phosphorylation: linking thermoregulatory deficit with Alzheimer's disease. Neurobiol Aging2017; 50: 25–29.
137.
VandalMWhitePJTournissacM, et al.Impaired thermoregulation and beneficial effects of thermoneutrality in the 3×Tg-AD model of Alzheimer's disease. Neurobiol Aging2016; 43: 47–57.
138.
Khoury NBEGratuzeMPetryF, et al.Hypothermia mediates age-dependent increase of tau phosphorylation in db/db mice. Neurobiol Dis2016; 88: 55–65.
139.
HafenPSAbbottKBowdenJ, et al.Daily heat treatment maintains mitochondrial function and attenuates atrophy in human skeletal muscle subjected to immobilization. J Appl Physiol (1985)2019; 127: 47–57.
140.
BruntVEEymannTMFranciscoMA, et al.Passive heat therapy improves cutaneous microvascular function in sedentary humans via improved nitric oxide-dependent dilation. J Appl Physiol (1985)2016; 121: 716–723.
141.
ZalewskiPZawadka-KunikowskaMSłomkoJ, et al.Cardiovascular and thermal response to dry-sauna exposure in healthy subjects. Physiol J2014; 2014: 106049.
142.
LaukkanenTKunutsorSKauhanenJ, et al.Sauna bathing is inversely associated with dementia and Alzheimer's disease in middle-aged Finnish men. Age Ageing2017; 46: 245–249.
143.
Gordon-WeeksPR. The role of the drebrin/EB3/Cdk5 pathway in dendritic spine plasticity, implications for Alzheimer's disease. Brain Res Bull2016; 126: 293–299.
144.
LiuYXuYZhangL, et al.Down-regulated drebrin aggravates cognitive impairments in a mouse model of Alzheimer's disease. Int J Mol Sci2017; 18: 800.
145.
Van GoolBStorckSEReekmansSM, et al.LRP1 Has a predominant role in production over clearance of Aβ in a mouse model of Alzheimer's disease. Mol Neurobiol2019; 56: 7234–7245.
146.
MaQZhaoZSagareAP, et al.Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism. Mol Neurodegener2018; 13: 57.
147.
TournissacMBourassaPMartinez-CanoRD, et al.Repeated cold exposures protect a mouse model of Alzheimer's disease against cold-induced tau phosphorylation. Mol Metab2019; 22: 110–120.
148.
XuZYouWZhouY, et al.Cold-induced lipid dynamics and transcriptional programs in white adipose tissue. BMC Biol2019; 17: 1–21.
149.
GotoSKamalNPuzioH, et al.Differential responses of individuals with late-stage dementia to two novel environments: a multimedia room and an interior garden. J Alzheimers Dis2014; 42: 985–998.
150.
Rivasseau JonveauxTBattMFescharekR, et al.Healing gardens and cognitive behavioral units in the management of Alzheimer's disease patients: the Nancy experience. J Alzheimers Dis2013; 34: 325–338.
151.
GueibCPopABannayA, et al.Impact of a healing garden on self-consciousness in patients with advanced Alzheimer's disease: an exploratory study. J Alzheimers Dis2020; 75: 1283–1300.
152.
ParkMJKimDJLeeU, et al.A literature overview of virtual reality (VR) in treatment of psychiatric disorders: recent advances and limitations. Front Psychiatry2019; 10: 505.
153.
OptaleGUrgesiCBusatoV, et al.Controlling memory impairment in elderly adults using virtual reality memory training: a randomized controlled pilot study. Neurorehabil Neural Repair2010; 24: 348–357.
154.
Da MesquitaSLouveauAVaccariA, et al.Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease. Nature2018; 560: 185–191.
155.
ZhangBLiWZhuoY, et al.L-3-n-butylphthalide effectively improves the glymphatic clearance and reduce amyloid-β deposition in Alzheimer's transgenic mice. J Mol Neurosci2021; 71: 1266–1274.
156.
LeeYChoiYParkE-J, et al.Improvement of glymphatic-lymphatic drainage of beta-amyloid by focused ultrasound in Alzheimer's disease model. Sci Rep2020; 10: 16144.
157.
ZhouX-BZhangY-XZhouC-X, et al.Chinese Herbal medicine adjusting brain microenvironment via mediating central nervous system lymphatic drainage in Alzheimer's disease. Chin J Integr Med2022; 28: 176–184.
158.
von Holstein-RathlouSPetersenNCNedergaardM. Voluntary running enhances glymphatic influx in awake behaving, young mice. Neurosci Lett2018; 662: 253–258.
159.
FormoloDAYuJLinK, et al.Leveraging the glymphatic and meningeal lymphatic systems as therapeutic strategies in Alzheimer's disease: an updated overview of nonpharmacological therapies. Mol Neurodegener2023; 18: 26.
160.
WangMYanCLiX, et al.Non-invasive modulation of meningeal lymphatics ameliorates ageing and Alzheimer's disease-associated pathology and cognition in mice. Nat Commun2024; 15: 1453.
161.
LiuYHuP-PZhaiS, et al.Aquaporin 4 deficiency eliminates the beneficial effects of voluntary exercise in a mouse model of Alzheimer's disease. Neural Regen Res2022; 17: 2079–2088.
162.
HeX-FLiuD-XZhangQ, et al.Voluntary exercise promotes glymphatic clearance of amyloid beta and reduces the activation of astrocytes and microglia in aged mice. Front Mol Neurosci2017; 10: 144.
163.
BroomGMShawICRucklidgeJJ. The ketogenic diet as a potential treatment and prevention strategy for Alzheimer's disease. Nutrition2019; 60: 118–121.
164.
MorrisMCTangneyCCWangY, et al.MIND Diet associated with reduced incidence of Alzheimer's disease. Alzheimers Dement2015; 11: 1007–1014.
165.
ZhengXYangHZhaoYZ, et al.Advances in royal jelly adjuvant treatment for Alzheimer's disease. Apiculture China2021; 72: 55–59.
166.
KhalsaDS. Stress, meditation, and Alzheimer's disease prevention: where the evidence stands. J Alzheimers Dis2015; 48: 1–12.
167.
LiuZYangFLouY, et al.The effectiveness of reminiscence therapy on alleviating depressive symptoms in older adults: a systematic review. Front Psychol2021; 12: 709853.
168.
ButlerRN. The life review: an interpretation of reminiscence in the aged. Psychiatry1963; 26: 65–76.
169.
Pérez-SáezEJusto-HenriquesSIAlves ApóstoloJL. Multicenter randomized controlled trial of the effects of individual reminiscence therapy on cognition, depression and quality of life: analysis of a sample of older adults with Alzheimer's disease and vascular dementia. Clin Neuropsychol2022; 36: 1975–1996.
170.
YangCYangQXiangY, et al.The neuroprotective effects of oxygen therapy in Alzheimer's disease: a narrative review. Neural Regen Res2023; 18: 57–63.
171.
LiJLiLWangL. Effects of acupuncture combined with Baduanjin on behavioral ability and cognitive function of patients with Alzheimer's disease. Lab Med Clinic2021; 18: 2736–2739.
172.
LeinengaGLangtonCNisbetR, et al.Ultrasound treatment of neurological diseases–current and emerging applications. Nat Rev Neurol2016; 12: 161–174.
173.
LeinengaGGötzJ. Safety and efficacy of scanning ultrasound treatment of aged APP23 mice. Front Neurosci2018; 12: 55.
174.
LeinengaGKohWKGötzJ. A comparative study of the effects of Aducanumab and scanning ultrasound on amyloid plaques and behavior in the APP23 mouse model of Alzheimer disease. Alzheimers Res Ther2021; 13: 76.
175.
LeinengaGKohWKGötzJ. Scanning ultrasound in the absence of blood-brain barrier opening is not sufficient to clear β-amyloid plaques in the APP23 mouse model of Alzheimer's disease. Brain Res Bull2019; 153: 8–14.
176.
PanditRChenLGötzJ. The blood-brain barrier: physiology and strategies for drug delivery. Adv Drug Deliv Rev2020; 165-166: 1–14.
177.
NisbetRMVan der JeugdALeinengaG, et al.Combined effects of scanning ultrasound and a tau-specific single chain antibody in a tau transgenic mouse model. Brain2017; 140: 1220–1230.
178.
HsuP-HLinY-TChungY-H, et al.Focused ultrasound-induced blood-brain barrier opening enhances GSK-3 inhibitor delivery for amyloid-beta plaque reduction. Sci Rep2018; 8: 12882.
179.
DubeySHeinenSKranticS, et al.Clinically approved IVIg delivered to the hippocampus with focused ultrasound promotes neurogenesis in a model of Alzheimer's disease. Proc Natl Acad Sci U S A2020; 117: 32691–32700.
180.
ShinJKongCLeeJ, et al.Focused ultrasound-induced blood-brain barrier opening improves adult hippocampal neurogenesis and cognitive function in a cholinergic degeneration dementia rat model. Alzheimers Res Ther2019; 11: 110.
181.
PoonCTShahKLinC, et al.Time course of focused ultrasound effects on β-amyloid plaque pathology in the TgCRND8 mouse model of Alzheimer's disease. Sci Rep2018; 8: 14061.
182.
BobolaMSChenLEzeokekeCK, et al.Transcranial focused ultrasound, pulsed at 40 Hz, activates microglia acutely and reduces Aβ load chronically, as demonstrated in vivo. Brain Stimul2020; 13: 1014–1023.
183.
BeisteinerRMattEFanC, et al.Transcranial pulse stimulation with ultrasound in Alzheimer's disease-A new navigated focal brain therapy. Adv Sci (Weinh)2020; 7: 1902583.
184.
LiuXNaomiSSMSharonWL, et al.The applications of focused ultrasound (FUS) in Alzheimer's disease treatment: a systematic review on both animal and human studies. Aging Dis2021; 12: 1977–2002.
